RC
Rangeley Capital Portfolio holdings
AUM
$79.7M
This Quarter Return
-8.4%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$88.6M
AUM Growth
+$88.6M
(-16%)
Cap. Flow
-$3.37M
Cap. Flow
% of AUM
-3.8%
Top 10 Holdings %
Top 10 Hldgs %
49.88%
Holding
103
New
26
Increased
11
Reduced
26
Closed
26
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$4.16M |
| 2 |
Arvinas
ARVN
|
$3.81M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$3.06M |
| 4 |
Surgery Partners
SGRY
|
$2.16M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.47M |
Top Sells
| 1 |
DRDBU
Roman DBDR Acquisition Corp. II Unit
DRDBU
|
$2.17M |
| 2 |
NLOP
Net Lease Office Properties
NLOP
|
$1.8M |
| 3 |
Burford Capital
BUR
|
$1.45M |
| 4 |
SMC
Summit Midstream Corporation
SMC
|
$1.45M |
| 5 |
Target Hospitality
TH
|
$1.39M |
Sector Composition
| 1 | Healthcare | 30.18% |
| 2 | Energy | 16.93% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Real Estate | 9.79% |
| 5 | Materials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Calumet Specialty Products
CLMT
$1.41B
| $6.59M | 7.06% | 519,787 -14,813 | -3% | -$188K |
|
2
Delek US
DK
$1.67B
| $5.11M | 5.47% | 339,000 +5,000 | +1% | +$75.4K |
|
3
Arbutus Biopharma
ABUS
$711M
| $4.71M | 5.04% | 1,349,000 -110,000 | -8% | -$384K |
|
|
4
Burford Capital
BUR
$3.06B
| $4.64M | 4.97% | 351,000 -110,000 | -24% | -$1.45M |
|
5
Amplify Energy
AMPY
$165M
| $4.19M | 4.49% | 1,120,000 -239,000 | -18% | -$894K |
|
|
6
Keros Therapeutics
KROS
$618M
| $4.16M | 4.46% | +408,234 | New | +$4.16M |
|
|
7
Arvinas
ARVN
$568M
| $3.81M | 4.08% | +543,000 | New | +$3.81M |
|
8
WideOpenWest
WOW
$437M
| $3.75M | 4.01% | 757,248 +6,908 | +0.9% | +$34.2K |
|
9
Full House Resorts
FLL
$132M
| $3.72M | 3.98% | 889,104 +101,226 | +13% | +$423K |
|
|
SEG
10
Seaport Entertainment Group Inc.
SEG
$318M
| $3.53M | 3.78% | 164,500 +5,230 | +3% | +$112K |
|
|
NLOP
11
Net Lease Office Properties
NLOP
$439M
| $3.45M | 3.7% | 110,064 -57,436 | -34% | -$1.8M |
|
|
SAGE
12
DELISTED
Sage Therapeutics
SAGE
| $3.06M | 3.28% | +384,687 | New | +$3.06M |
|
13
Genesis Energy
GEL
$2.08B
| $2.97M | 3.18% | 189,000 -22,000 | -10% | -$345K |
|
14
Liquidia Corp
LQDA
$2.38B
| $2.36M | 2.53% | 160,000 -31,000 | -16% | -$457K |
|
|
15
Surgery Partners
SGRY
$2.91B
| $2.16M | 2.31% | +90,900 | New | +$2.16M |
|
16
Par Pacific Holdings
PARR
$1.76B
| $2.02M | 2.16% | 141,687 +12,584 | +10% | +$179K |
|
17
Cadiz
CDZI
$294M
| $1.85M | 1.98% | 630,000 -30,000 | -5% | -$87.9K |
|
18
CVR Partners
UAN
$948M
| $1.74M | 1.87% | 23,183 -817 | -3% | -$61.4K |
|
|
CEE
19
Central and Eastern Europe Fund
CEE
$105M
| $1.64M | 1.76% | 113,892 +2,892 | +3% | +$41.7K |
|
20
Hilton Grand Vacations
HGV
$4.24B
| $1.57M | 1.68% | 42,000 +1,000 | +2% | +$37.4K |
|
|
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
| $1.47M | 1.58% | +33,400 | New | +$1.47M |
|
22
Roivant Sciences
ROIV
$8.15B
| $1.41M | 1.51% | 140,178 -98,822 | -41% | -$997K |
|
23
Liberty Broadband Class A
LBRDA
$8.71B
| $1.4M | 1.5% | 16,500 | – | – |
|
24
Jack in the Box
JACK
$364M
| $1.2M | 1.28% | 44,000 +16,500 | +60% | +$449K |
|
25
BankFinancial
BFIN
$154M
| $1.12M | 1.2% | 89,000 | – | – |
|